Agah Ramtin 4
4 · RenovoRx, Inc. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Purchase
Common Stock
2025-11-21$0.80/sh+10,000$8,000→ 744,460 total - Purchase
Common Stock
2025-11-24$0.80/sh+12,000$9,600→ 756,460 total
Footnotes (1)
- [F1]Reflects open market purchases of the Issuer's securities.